SS
ASMB icon

SBI Securities’s Assembly Biosciences ASMB Stock Holding History

SBI Securities’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-68
Closed -$1.74K – 4029
2025
Q3 		$1.74K Buy
68
+1
+1% +$22 ﹤0.01% 2467
2025
Q2 		$1.21K Hold
67
– – ﹤0.01% 2594
2025
Q1 		$641 Hold
67
– – ﹤0.01% 2770
2024
Q4 		$1.06K Buy
+67
New +$1.08K ﹤0.01% 2580

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

SBI Securities's ASMB Position: Q4 2025 in Review

SBI Securities sold out of Assembly Biosciences (ASMB) in Q4 2025, closing a stake of 68 shares — an estimated $1.74K sold.

SBI Securities first reported a position in ASMB in Q4 2024 and held it in 4 quarters. The position peaked at $1.74K in Q3 2025. 69 funds tracked by Wall St. Rank hold ASMB as of Q4 2025.

  • SBI Securities reported no remaining Assembly Biosciences position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 68 Assembly Biosciences shares in Q4 2025, an estimated $1.74K.
  • SBI Securities first reported a position in Assembly Biosciences in Q4 2024 and held it in 4 quarters.
  • SBI Securities's Assembly Biosciences position peaked at $1.74K in Q3 2025.
  • 69 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.